Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Pregnancy Outcomes in Primigravida Receiving Low-Dose Aspirin for the Prevention of Preeclampsia.
Sponsor: Muhammad Aamir Latif
Summary
Local data on the effectiveness of low-dose aspirin in high-risk primigravida are limited. The present study was planned to compare pregnancy outcomes between high-risk primigravida receiving low-dose aspirin (75 mg/day) from 12 weeks of gestation and those not receiving aspirin.
Official title: Low-Dose Aspirin: A Game-Changer in Preventing Pre-Eclampsia and Adverse Pregnancy Outcomes in Primigravida
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2025-08-01
Completion Date
2026-06-30
Last Updated
2026-10-01
Healthy Volunteers
No
Conditions
Interventions
Low-dose aspirin
Participants received low-dose aspirin (75 mg) once daily, starting at 12 weeks of gestation and continuing until 36 weeks of gestation or delivery, along with standard care.
No-Aspirin
Participants received standard antenatal care without aspirin.
Locations (1)
Bahawal Victoria Hospital/Quaid-e-Azam Medical College
Bahawalpur, Punjab Province, Pakistan